BSEVEERHEALTH CARE LIMITED· Pharmaceuticals & BiotechnologyHighPositive
Announced Tue, 4 Aug, 2026 · 17:27 IST

Veerhealth Care wins Rs 526.84 lakh skincare order from leading FMCG firm

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.1%Reaction day
₹43.97
prior close
₹43.83
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.3%-1.2% vs market
Pharmaceuticals peers, median of 165sector-0.0%+0.1% vs sector

On the reaction day the stock moved 1.2 pts less than Nifty Microcap 250 and 0.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.3
10m
+0.3
15m
+0.4
30m
+0.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.1+1.3-1.2-0.0+0.1
Next day
+0.2+1.6-1.4+0.1+0.1
2d
+0.3+1.7-1.4+0.4-0.1
3d
+5.3+1.6+3.7+1.0+4.3
4d
+5.8+1.5+4.3+1.2+4.6
5d
+6.7+1.8+4.8+1.0+5.7
1w
+6.5+2.1+4.5+0.5+6.1
15d
+13.4+3.2+10.3-0.0+13.5
1m
+13.5+3.7+9.8+1.7+11.8
2m
+14.3+1.1+13.2+1.0+13.3
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Veerhealth Care Limited has received an order valued at Rs 526.84 Lakhs from one of India's largest FMCG companies for the supply of face care/skincare products. The order is domestic in nature, to be executed within 45 days. The customer name has not been disclosed citing confidentiality. The company says this represents a significant opportunity and expects additional turnover growth. No promoter or related party interest in the awarding entity.

Likely market impact

Adds about Rs 5.27 crores in near-term revenue visibility with a quick 45-day execution window; positive but modest-sized win.